Indeed, as mentioned above, IL-13 collaborates with TGF-β in fibrosis development, given that IL-13 expression is increased in NASH murine model, and the hepatic beneficial effects of IL-13/TGF-β blockade are more evident than TGF-β blockade alone [122]. This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatohepatitis.